Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan J Knox

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Radiation Research|January 5, 2002
The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiationShoucheng Ning, Douglas Laird, Julie M Cherrington, et al.
Cancer Research|September 16, 2010
Anti-alphav integrin monoclonal antibody intetumumab enhances the efficacy of radiation therapy and reduces metastasis of human cancer xenografts in nude ratsShoucheng Ning, Junqiang Tian, Deborah J Marshall, et al.
Molecular Cancer Therapeutics|August 25, 2006
Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of actionBryan Husbeck, Rumi S Bhattacharyya, David Feldman, et al.
Biochemical and Biophysical Research Communications|April 17, 2014
Novel nitric oxide generating compound glycidyl nitrate enhances the therapeutic efficacy of chemotherapy and radiotherapyShoucheng Ning, Mark Bednarski, Bryan Oronsky, et al.
Clinical Immunology (Orlando, Fla.)|May 8, 2013
Characterization of direct radiation-induced immune function and molecular signaling changes in an antigen presenting cell lineJennifer J Parker, Jennifer C Jones, Samuel Strober, et al.
Drugs in R&D|April 18, 2021
Clinical Pharmacokinetics of Oral Sodium Selenite and Dosing Implications in the Treatment of Patients with Metastatic CancerPriya Jayachandran, Susan J Knox, Maria Garcia-Cremades, et al.
Seminars in Oncology|June 11, 2020
Just eat it: A review of CD47 and SIRP-α antagonismBryan Oronsky, Corey Carter, Tony Reid, et al.
Translational Oncology|September 1, 2012
The scarlet letter of alkylation: a mini review of selective alkylating agentsBryan T Oronsky, Tony Reid, Susan J Knox, et al.
Frontiers in Oncology|February 22, 2021
A Review of Newly Diagnosed GlioblastomaBryan Oronsky, Tony R Reid, Arnold Oronsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2017
Phase I Trial: SABR and Ipilimumab-LetterSusan M Hiniker, Sunil A Reddy, Susan M Swetter, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Radiation Research|January 5, 2002
The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiationShoucheng Ning, Douglas Laird, Julie M Cherrington, et al.
Cancer Research|September 16, 2010
Anti-alphav integrin monoclonal antibody intetumumab enhances the efficacy of radiation therapy and reduces metastasis of human cancer xenografts in nude ratsShoucheng Ning, Junqiang Tian, Deborah J Marshall, et al.
Molecular Cancer Therapeutics|August 25, 2006
Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of actionBryan Husbeck, Rumi S Bhattacharyya, David Feldman, et al.
Biochemical and Biophysical Research Communications|April 17, 2014
Novel nitric oxide generating compound glycidyl nitrate enhances the therapeutic efficacy of chemotherapy and radiotherapyShoucheng Ning, Mark Bednarski, Bryan Oronsky, et al.
Clinical Immunology (Orlando, Fla.)|May 8, 2013
Characterization of direct radiation-induced immune function and molecular signaling changes in an antigen presenting cell lineJennifer J Parker, Jennifer C Jones, Samuel Strober, et al.
Drugs in R&D|April 18, 2021
Clinical Pharmacokinetics of Oral Sodium Selenite and Dosing Implications in the Treatment of Patients with Metastatic CancerPriya Jayachandran, Susan J Knox, Maria Garcia-Cremades, et al.
Seminars in Oncology|June 11, 2020
Just eat it: A review of CD47 and SIRP-α antagonismBryan Oronsky, Corey Carter, Tony Reid, et al.
Translational Oncology|September 1, 2012
The scarlet letter of alkylation: a mini review of selective alkylating agentsBryan T Oronsky, Tony Reid, Susan J Knox, et al.
Frontiers in Oncology|February 22, 2021
A Review of Newly Diagnosed GlioblastomaBryan Oronsky, Tony R Reid, Arnold Oronsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2017
Phase I Trial: SABR and Ipilimumab-LetterSusan M Hiniker, Sunil A Reddy, Susan M Swetter, et al.
Pageof 8